Lymphoproliferation and hyper-IgM as the first manifestation of activated phosphoinositide 3-kinase δ syndrome: A case report

Activated phosphoinositide 3-kinase δ syndrome is an inborn error of immunity due to mutations within the genes responsible for encoding PI3Kδ subunits. This syndrome results in an excessive activation of the phosphoinositide 3-kinase signaling pathway. Gainof-function mutations in the gene PIK3R1 (...

Full description

Saved in:
Bibliographic Details
Main Authors: Mónica Fernandes-Pineda, Andrés F. Zea-Vera
Format: Article
Language:English
Published: Instituto Nacional de Salud 2024-12-01
Series:Biomédica: revista del Instituto Nacional de Salud
Subjects:
Online Access:https://revistabiomedica.org/index.php/biomedica/article/view/7436
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832592049623269376
author Mónica Fernandes-Pineda
Andrés F. Zea-Vera
author_facet Mónica Fernandes-Pineda
Andrés F. Zea-Vera
author_sort Mónica Fernandes-Pineda
collection DOAJ
description Activated phosphoinositide 3-kinase δ syndrome is an inborn error of immunity due to mutations within the genes responsible for encoding PI3Kδ subunits. This syndrome results in an excessive activation of the phosphoinositide 3-kinase signaling pathway. Gainof-function mutations in the gene PIK3R1 (encoding p85α, p55α, and p50α) lead to the development of the activated PI3K δ syndrome. Notably, the clinical presentations of this syndrome often closely resemble those of other primary immunodeficiencies. We present a case involving a 15-year-old male who displayed an immunological phenotype that bore a striking resemblance to hyper-IgM syndrome. Whole exome sequencing was undertaken to pinpoint the underlying genetic mutation. Our investigation successfully identified a heterozygous splice site mutation previously reported within the well-established hotspot of the PIK3R1 gene (GRCh37, c.1425+1 G>T). The diverse spectrum of inborn errors of immunity underscores the pivotal role of identifying gene mutations, particularly in patients presenting clinical manifestations spanning autoimmune disorders, lymphoproliferative conditions, and antibody deficiencies. Such precise genetic diagnoses hold significant potential for improving patient care and management.
format Article
id doaj-art-19ff888161b34f88998f6f45ae13f4db
institution Kabale University
issn 0120-4157
language English
publishDate 2024-12-01
publisher Instituto Nacional de Salud
record_format Article
series Biomédica: revista del Instituto Nacional de Salud
spelling doaj-art-19ff888161b34f88998f6f45ae13f4db2025-01-21T18:56:10ZengInstituto Nacional de SaludBiomédica: revista del Instituto Nacional de Salud0120-41572024-12-0144Sp. 2101510.7705/biomedica.74368891Lymphoproliferation and hyper-IgM as the first manifestation of activated phosphoinositide 3-kinase δ syndrome: A case reportMónica Fernandes-Pineda0https://orcid.org/0000-0003-4891-543XAndrés F. Zea-Vera1https://orcid.org/0000-0001-9127-3677Departamento de Medicina Interna, Universidad del Valle, Cali, ColombiaDepartamento de Microbiología, Facultad de Salud, Universidad del Valle, Cali, Colombia; Genetic Immunotherapy Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Disorders, National Institutes of Health, Bethesda, MD, USAActivated phosphoinositide 3-kinase δ syndrome is an inborn error of immunity due to mutations within the genes responsible for encoding PI3Kδ subunits. This syndrome results in an excessive activation of the phosphoinositide 3-kinase signaling pathway. Gainof-function mutations in the gene PIK3R1 (encoding p85α, p55α, and p50α) lead to the development of the activated PI3K δ syndrome. Notably, the clinical presentations of this syndrome often closely resemble those of other primary immunodeficiencies. We present a case involving a 15-year-old male who displayed an immunological phenotype that bore a striking resemblance to hyper-IgM syndrome. Whole exome sequencing was undertaken to pinpoint the underlying genetic mutation. Our investigation successfully identified a heterozygous splice site mutation previously reported within the well-established hotspot of the PIK3R1 gene (GRCh37, c.1425+1 G>T). The diverse spectrum of inborn errors of immunity underscores the pivotal role of identifying gene mutations, particularly in patients presenting clinical manifestations spanning autoimmune disorders, lymphoproliferative conditions, and antibody deficiencies. Such precise genetic diagnoses hold significant potential for improving patient care and management.https://revistabiomedica.org/index.php/biomedica/article/view/7436immune system diseasesphosphatidylinositol 3-kinasehyper-igm immunodeficiency syndromeautoimmunityhuman geneticsgenetic testing
spellingShingle Mónica Fernandes-Pineda
Andrés F. Zea-Vera
Lymphoproliferation and hyper-IgM as the first manifestation of activated phosphoinositide 3-kinase δ syndrome: A case report
Biomédica: revista del Instituto Nacional de Salud
immune system diseases
phosphatidylinositol 3-kinase
hyper-igm immunodeficiency syndrome
autoimmunity
human genetics
genetic testing
title Lymphoproliferation and hyper-IgM as the first manifestation of activated phosphoinositide 3-kinase δ syndrome: A case report
title_full Lymphoproliferation and hyper-IgM as the first manifestation of activated phosphoinositide 3-kinase δ syndrome: A case report
title_fullStr Lymphoproliferation and hyper-IgM as the first manifestation of activated phosphoinositide 3-kinase δ syndrome: A case report
title_full_unstemmed Lymphoproliferation and hyper-IgM as the first manifestation of activated phosphoinositide 3-kinase δ syndrome: A case report
title_short Lymphoproliferation and hyper-IgM as the first manifestation of activated phosphoinositide 3-kinase δ syndrome: A case report
title_sort lymphoproliferation and hyper igm as the first manifestation of activated phosphoinositide 3 kinase δ syndrome a case report
topic immune system diseases
phosphatidylinositol 3-kinase
hyper-igm immunodeficiency syndrome
autoimmunity
human genetics
genetic testing
url https://revistabiomedica.org/index.php/biomedica/article/view/7436
work_keys_str_mv AT monicafernandespineda lymphoproliferationandhyperigmasthefirstmanifestationofactivatedphosphoinositide3kinasedsyndromeacasereport
AT andresfzeavera lymphoproliferationandhyperigmasthefirstmanifestationofactivatedphosphoinositide3kinasedsyndromeacasereport